Sun Pharmaceutical Industries share price
You have to be logged in to add this to Watchlist.Sun Pharmaceutical Industries is trading -0.15% lower at Rs 1,795.15 as compared to its last closing price. Sun Pharmaceutical Industries has been trading in the price range of 1,826.10 & 1,784.50. Sun Pharmaceutical Industries has given 42.55% in this year & 0.92% in the last 5 days.
Sun Pharmaceutical Industries has TTM P/E ratio 41.78 as compared to the sector P/E of 33.29.There are 33 analysts who have initiated coverage on Sun Pharmaceutical Industries. There are 10 analysts who have given it a strong buy rating & 12 analysts have given it a buy rating. 3 analysts have given the stock a sell rating.
The company posted a net profit of 3,040.16 Crores in its last quarter.
Listed peers of Sun Pharmaceutical Industries include Sun Pharmaceutical Industries (-0.15%), Divis Laboratories (1.59%), Cipla (1.14%) etc.
Sun Pharmaceutical Industries has a 45.52% public holding.The Mutual Fund holding in Sun Pharmaceutical Industries was at 12.11% in 30 Sep 2024. The MF holding has decreased from the last quarter. The FII holding in Sun Pharmaceutical Industries was at 18.01% in 30 Sep 2024. The FII holding has increased from the last quarter.
Sun Pharmaceutical Industries share price range
|
| ||||
|
| ||||
Sun Pharmaceutical Industries share Key Metrics
| Market Cap ( ₹ Cr.) | 4,30,752.60 | ||||||||||||||||||
|
|
Technical Trends
Long TermConsiders price movement over the last 6 months
Short TermConsiders price movement over the last 1-2 weeks
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Sun Pharmaceutical Industries Corporate actions
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
| 28-Oct-24 | Quarterly Results |
| 01-Aug-24 | Quarterly Results |
| 22-May-24 | Audited Results & Final Dividend |
| 31-Jan-24 | Quarterly Results & Interim Dividend |
| 01-Nov-23 | Quarterly Results |
| 03-Aug-23 | Quarterly Results |
| 26-May-23 | Audited Results & Final Dividend |
| 31-Jan-23 | Quarterly Results & Interim Dividend |
| 01-Nov-22 | Quarterly Results |
| 29-Jul-22 | Quarterly Results |
| Meeting Date | Announcement On | Purpose |
| 05-Aug-24 | 19-Jun-24 | AGM |
| 28-Aug-23 | 07-Jul-23 | AGM |
| 29-Aug-22 | 03-Aug-22 | AGM |
| 31-Aug-21 | 04-Aug-21 | AGM |
| 16-Mar-21 | 05-Feb-21 | COM |
| 27-Aug-20 | 29-Jul-20 | AGM |
| 28-Aug-19 | 26-Jul-19 | AGM |
| 04-Jun-19 | 30-Apr-19 | COM |
| Announcement On | Record Date | Ex-Dividend | Dividend Value |
| 22-May-24 | 12-Jul-24 | 12-Jul-24 | 5 |
| 15-Jan-24 | 09-Feb-24 | 09-Feb-24 | 8.5 |
| 07-Jul-23 | 28-Jul-23 | 28-Jul-23 | 4 |
| 16-Jan-23 | 08-Feb-23 | 08-Feb-23 | 7.5 |
| 31-May-22 | 22-Aug-22 | 19-Aug-22 | 3 |
| 31-Jan-22 | 10-Feb-22 | 09-Feb-22 | 7 |
| 27-May-21 | - | 23-Aug-21 | 2 |
| 29-Jan-21 | 10-Feb-21 | 09-Feb-21 | 5.5 |
| 27-May-20 | - | 19-Aug-20 | 1 |
| 06-Feb-20 | 18-Feb-20 | 17-Feb-20 | 3 |
FAQs about Sun Pharmaceutical Industries share price
Sun Pharmaceutical Industries is trading at 1795.15 as on Mon Nov 25 2024 09:30:57. This is -0.15% lower as compared to its previous closing price of 1797.80.
The market capitalization of Sun Pharmaceutical Industries is 430752.60 Cr as on Mon Nov 25 2024 09:30:57.
The average broker rating on Sun Pharmaceutical Industries is Buy. The breakup of analyst rating is given below -
- 10 analysts have given a strong buy rating
- 12 analysts have given a buy rating
- 8 analysts have given a hold rating
- 3 analysts have given a sell rating
- 0 analysts have given a strong sell rating
The 52 wk high for Sun Pharmaceutical Industries is 1960.20 whereas the 52 wk low is 1180.10
Sun Pharmaceutical Industries can be analyzed on the following key metrics -
- TTM P/E: 41.78
- Sector P/E: 33.29
- Dividend Yield: 0.75%
- D/E ratio: 0.04
Sun Pharmaceutical Industries reported a net profit of 9576.38 Cr in 2024.
Sun Pharmaceutical Industries Quick Links
Sun Pharmaceutical Industries Dividend Sun Pharmaceutical Industries Bonus Sun Pharmaceutical Industries News Sun Pharmaceutical Industries AGM Sun Pharmaceutical Industries Rights Sun Pharmaceutical Industries Splits Sun Pharmaceutical Industries Board Meetings Sun Pharmaceutical Industries Key Metrics Sun Pharmaceutical Industries Shareholdings Sun Pharmaceutical Industries Profit Loss Sun Pharmaceutical Industries Balance Sheet Sun Pharmaceutical Industries Cashflow Sun Pharmaceutical Industries Q1 Results Sun Pharmaceutical Industries Q2 Results Sun Pharmaceutical Industries Q3 Results Sun Pharmaceutical Industries Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks